{"id":"https://openalex.org/W7225820550","doi":"https://doi.org/10.1186/s13048-026-02326-0","title":"Characterization of the single-cell adaptive immune landscape and its clinical implications in high-grade serous ovarian cancer","display_name":"Characterization of the single-cell adaptive immune landscape and its clinical implications in high-grade serous ovarian cancer","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225820550","doi":"https://doi.org/10.1186/s13048-026-02326-0"},"language":"en","primary_location":{"id":"doi:10.1186/s13048-026-02326-0","doi":"https://doi.org/10.1186/s13048-026-02326-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13048-026-02326-0","pdf_url":null,"source":{"id":"https://openalex.org/S15947008","display_name":"Journal of Ovarian Research","issn_l":"1757-2215","issn":["1757-2215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ovarian Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s13048-026-02326-0","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027560561","display_name":"Congli Pu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Congli Pu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115604249","display_name":"Teng Li","orcid":"https://orcid.org/0000-0003-2577-3985","observed_orcids":["https://orcid.org/0000-0003-2577-3985"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teng Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161467949","display_name":"ZiXuan Zhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ZiXuan Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161423134","display_name":"Yi Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161460344","display_name":"Xiaohang Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaohang Lu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051568830","display_name":"Shuqi Nie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuqi Nie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161455880","display_name":"Yixiu Long","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yixiu Long","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001773311","display_name":"Xuan Pei","orcid":"https://orcid.org/0000-0002-4654-2222","observed_orcids":["https://orcid.org/0000-0002-4654-2222"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xuan Pei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161422958","display_name":"Wei Jiang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Jiang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161477193","display_name":"Xiaoming Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoming Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5161460743","display_name":"Huijuan Yang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huijuan Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3290,"currency":"USD","value_usd":3290},"apc_paid":{"value":3290,"currency":"USD","value_usd":3290},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.5845000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.5845000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.3215000033378601,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.02319999970495701,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7070000171661377},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6438000202178955},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6385999917984009},{"id":"https://openalex.org/C128526571","wikidata":"https://www.wikidata.org/wiki/Q619302","display_name":"Somatic hypermutation","level":4,"score":0.5753999948501587},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.542900025844574},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4945000112056732},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4812000095844269},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4740999937057495},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4390999972820282},{"id":"https://openalex.org/C2993684365","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Serous ovarian cancer","level":4,"score":0.4255000054836273},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41040000319480896},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.38850000500679016},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.3856000006198883},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.37070000171661377},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3659999966621399},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.3474000096321106},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.3422999978065491},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.33959999680519104},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.3377000093460083},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.3239000141620636},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.3230000138282776},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.31040000915527344},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.3066999912261963},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3034000098705292},{"id":"https://openalex.org/C196166836","wikidata":"https://www.wikidata.org/wiki/Q902926","display_name":"Immunophenotyping","level":3,"score":0.30239999294281006},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.2985000014305115},{"id":"https://openalex.org/C2779175743","wikidata":"https://www.wikidata.org/wiki/Q156606","display_name":"Rhesus macaque","level":2,"score":0.2971999943256378},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.28760001063346863},{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.2802000045776367},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27799999713897705},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.275299996137619},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.2736999988555908}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1186/s13048-026-02326-0","doi":"https://doi.org/10.1186/s13048-026-02326-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13048-026-02326-0","pdf_url":null,"source":{"id":"https://openalex.org/S15947008","display_name":"Journal of Ovarian Research","issn_l":"1757-2215","issn":["1757-2215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ovarian Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1186/s13048-026-02326-0","doi":"https://doi.org/10.1186/s13048-026-02326-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13048-026-02326-0","pdf_url":null,"source":{"id":"https://openalex.org/S15947008","display_name":"Journal of Ovarian Research","issn_l":"1757-2215","issn":["1757-2215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ovarian Research","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"High-grade":[2],"serous":[3],"ovarian":[4],"cancer":[5],"(HGSOC)":[6],"remains":[7],"the":[8,42,47,61,112,166,226,234,298,361,406],"most":[9],"lethal":[10],"gynaecological":[11],"malignancy,":[12],"and":[13,29,52,58,68,80,89,98,102,109,121,130,154,158,161,168,186,198,222,237,260,270,273,280,292,306,315,335,344,378,396,405],"its":[14],"limited":[15],"response":[16],"to":[17,22,40,317,387],"immunotherapy":[18],"is":[19],"largely":[20],"attributed":[21],"poor":[23,271],"T":[24,57,65,101,184,201,375],"cell":[25,66,300,376],"infiltration,":[26],"functional":[27,48],"exhaustion,":[28],"an":[30,145,327,340,368],"incompletely":[31],"characterised":[32,251],"immune":[33,191,363],"microenvironment.":[34],"Although":[35],"single-cell":[36,92,358],"studies":[37],"have":[38],"begun":[39],"resolve":[41],"cellular":[43],"ecosystems":[44],"of":[45,55,165,219,304,360,408],"HGSOC,":[46,366],"states,":[49],"clonal":[50,217],"architecture,":[51],"clinical":[53],"relevance":[54],"tumour-infiltrating":[56],"B":[59,103,188,299,308],"lymphocytes\u2014particularly":[60],"interplay":[62],"between":[63],"immunosuppressive":[64,394],"subsets":[67],"protective":[69,383,397],"humoral":[70,398],"responses\u2014remain":[71],"poorly":[72],"defined.":[73],"Methods":[74],"We":[75,176,244],"prospectively":[76],"collected":[77],"paired":[78],"tumour":[79,227,302],"peripheral":[81],"blood":[82],"samples":[83],"from":[84,241],"five":[85],"treatment-na\u00efve":[86],"HGSOC":[87],"patients":[88],"performed":[90],"integrated":[91],"RNA":[93],"sequencing,":[94,97],"TCR/BCR":[95],"repertoire":[96],"flow":[99,142],"cytometry.":[100],"cells":[104,181,185,203,309],"were":[105,125,139,204],"isolated":[106],"by":[107,141,152,162,252,290,312],"FACS":[108],"profiled":[110],"using":[111,127],"10x":[113],"Genomics":[114],"platform.":[115],"Clonotype":[116],"diversity,":[117],"somatic":[118],"hypermutation":[119],"(SHM),":[120],"class-switch":[122],"recombination":[123],"(CSR)":[124],"analysed":[126],"scRepertoire,":[128],"SHazaM,":[129],"Alakazam.":[131],"Cell\u2013cell":[132],"communication":[133,275],"was":[134,193,265,288,310,326],"inferred":[135],"with":[136,172,230,267,283,339,400],"CellChat.":[137],"Findings":[138],"validated":[140],"cytometry":[143],"in":[144,156,206,212,294,332,349,365,411],"independent":[146,328],"cohort":[147],"(":[148],"n":[149],"=":[150],"33),":[151],"IHC":[153,291],"mIHC":[155,293,345],"platinum-sensitive":[157],"platinum-resistant":[159,295,350],"tumours,":[160,207],"CIBERSORT":[163],"deconvolution":[164],"TCGA":[167,334],"ICGC":[169,336],"OV":[170],"cohorts":[171],"survival":[173],"analysis.":[174],"Results":[175],"obtained":[177],"35,103":[178],"high-quality":[179],"single":[180],"comprising":[182],"17,667":[183],"17,436":[187],"cells.":[189],"The":[190],"landscape":[192,364],"highly":[194],"compartmentalised:":[195],"CD4":[196,223],"Tregs":[197,224],"CD8":[199,220,231,284,374],"exhausted":[200],"(Tex)":[202],"enriched":[205],"whereas":[208],"na\u00efve/memory":[209],"lymphocytes":[210],"predominated":[211],"blood.":[213],"TCR":[214],"analysis":[215,276],"revealed":[216,277],"expansion":[218,236],"Tex":[221,232,285],"within":[225],"microenvironment":[228],"(TME),":[229],"showing":[233],"greatest":[235],"a":[238,246,356,382],"differentiation":[239],"trajectory":[240],"Teff/Tm":[242],"precursors.":[243],"identified":[245],"tumour-enriched":[247],"HLADR-high":[248,369],"Treg":[249],"subset":[250,264],"elevated":[253],"MHC":[254],"class":[255],"II":[256],"expression,":[257],"oxidative":[258],"phosphorylation,":[259],"TNFR2":[261],"upregulation.":[262],"This":[263,353],"associated":[266,338],"platinum":[268,379],"resistance":[269],"survival,":[272],"cell\u2013cell":[274],"dense":[278],"TNFR2-":[279],"MIF/IL16-mediated":[281],"crosstalk":[282],"cells,":[286],"which":[287],"corroborated":[289],"tumours.":[296],"On":[297],"side,":[301],"infiltration":[303],"plasmablasts":[305,348],"memory":[307],"accompanied":[311],"active":[313,342],"SHM":[314],"CSR":[316],"IgG/IgA,":[318],"indicating":[319],"antigen-driven":[320],"activation.":[321],"A":[322],"high":[323],"plasmablast":[324,384],"signature":[325,385],"favourable":[329,388],"prognostic":[330],"factor":[331],"both":[333],"cohorts,":[337],"immunologically":[341],"TME,":[343],"confirmed":[346],"fewer":[347],"tumours":[351],"Conclusion":[352],"study":[354],"provides":[355],"comprehensive":[357],"atlas":[359],"adaptive":[362],"revealing":[367],"Treg\u2013TNFR2":[370],"axis":[371],"that":[372],"drives":[373],"exhaustion":[377],"resistance,":[380],"alongside":[381],"linked":[386],"prognosis.":[389],"These":[390],"findings":[391],"highlight":[392],"key":[393],"drivers":[395],"responses,":[399],"implications":[401],"for":[402],"patient":[403],"stratification":[404],"development":[407],"combination":[409],"immunotherapies":[410],"HGSOC.":[412]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}